“Generative AI will change many things about business, but it won’t change the importance of great leadership. At McKinsey, we continue to focus on recruiting and developing leaders who are endlessly curious, humble and resilient—people who have the aptitude to learn new things, think critically and lift those around them,” says McKinsey Global Managing Partner Bob Sternfels. “The individuals who will thrive will be those who set bold aspirations, invest in relationships with teammates, and bring creativity and empathy to every challenge.”

This year, companies in life sciences and healthcare are the most represented in the rankings, with 26 organizations, illustrating the growing prominence of leadership development within these fields. Mass General Brigham—where the CEO of CRISPR treatment maker Vertex Pharmaceuticals, Reshma Kewalramani, completed her medical residency—is ranked at no. 3. Several other major healthcare systems have also risen in ranks compared to last year. The COVID pandemic and other public health issues have brought more attention to the health care industry’s long-standing challenges, like staffing shortages, physician and nurse burnout, and the rising costs of care. However, these disruptions can often create space for innovations in treatment, while also empowering new leaders with fresh ideas on how to make the system work better.